BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 34433706)

  • 1. VISTA Stimulation of VSIG4-Positive Macrophages Strongly Suppresses T Cell Proliferation via Excessive Nitric Oxide Production in Sepsis.
    Lee SW
    Biol Pharm Bull; 2021 Nov; 44(11):1645-1652. PubMed ID: 34433706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective role of V-set and immunoglobulin domain-containing 4 expressed on kupffer cells during immune-mediated liver injury by inducing tolerance of liver T- and natural killer T-cells.
    Jung K; Kang M; Park C; Hyun Choi Y; Jeon Y; Park SH; Seo SK; Jin D; Choi I
    Hepatology; 2012 Nov; 56(5):1838-48. PubMed ID: 22711680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-Affinity Anti-VISTA Antibody Protects against Sepsis by Inhibition of T Lymphocyte Apoptosis and Suppression of the Inflammatory Response.
    Tao T; Bo L; Li T; Shi L; Zhang H; Ye B; Xu Y; Ma Q; Deng X; Zhang G
    Mediators Inflamm; 2021; 2021():6650329. PubMed ID: 34366711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VSIG4(+) peritoneal macrophages induce apoptosis of double-positive thymocyte via the secretion of TNF-α in a CLP-induced sepsis model resulting in thymic atrophy.
    Cho HY; Yang YG; Jeon Y; Lee CK; Choi I; Lee SW
    Cell Death Dis; 2021 May; 12(6):526. PubMed ID: 34023853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous VSIG4 negatively regulates the helper T cell-mediated antibody response.
    Jung K; Seo SK; Choi I
    Immunol Lett; 2015 Jun; 165(2):78-83. PubMed ID: 25929804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular stimulation of VSIG4/complement receptor Ig suppresses intracellular bacterial infection by inducing autophagy.
    Kim KH; Choi BK; Kim YH; Han C; Oh HS; Lee DG; Kwon BS
    Autophagy; 2016 Sep; 12(9):1647-59. PubMed ID: 27440002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulatory molecule VSIG4 exclusively expressed on macrophages alleviates renal tubulointerstitial injury in VSIG4 KO mice.
    Li Y; Wang YQ; Wang DH; Hou WP; Zhang Y; Li M; Li FR; Mu J; Du X; Pang F; Yuan FH
    J Nephrol; 2014 Feb; 27(1):29-36. PubMed ID: 24424721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. VSIG4, a B7 family-related protein, is a negative regulator of T cell activation.
    Vogt L; Schmitz N; Kurrer MO; Bauer M; Hinton HI; Behnke S; Gatto D; Sebbel P; Beerli RR; Sonderegger I; Kopf M; Saudan P; Bachmann MF
    J Clin Invest; 2006 Oct; 116(10):2817-26. PubMed ID: 17016562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V-set and Ig domain-containing 4 (VSIG4)-expressing hepatic F4/80
    Shin W; Jeon Y; Choi I; Kim YJ
    Eur J Immunol; 2018 Apr; 48(4):632-643. PubMed ID: 29235119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VISTA nonredundantly regulates proliferation and CD69low γδ T cell accumulation in the intestine in murine sepsis.
    Gray CC; Armstead BE; Chung CS; Chen Y; Ayala A
    J Leukoc Biol; 2024 May; 115(6):1005-1019. PubMed ID: 38035776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VSIG4 expression on macrophages facilitates lung cancer development.
    Liao Y; Guo S; Chen Y; Cao D; Xu H; Yang C; Fei L; Ni B; Ruan Z
    Lab Invest; 2014 Jul; 94(7):706-15. PubMed ID: 24862966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies Targeting Human or Mouse VSIG4 Repolarize Tumor-Associated Macrophages Providing the Potential of Potent and Specific Clinical Anti-Tumor Response Induced across Multiple Cancer Types.
    Sazinsky S; Zafari M; Klebanov B; Ritter J; Nguyen PA; Phennicie RT; Wahle J; Kauffman KJ; Razlog M; Manfra D; Feldman I; Novobrantseva T
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The biology of VSIG4: Implications for the treatment of immune-mediated inflammatory diseases and cancer.
    Liu B; Cheng L; Gao H; Zhang J; Dong Y; Gao W; Yuan S; Gong T; Huang W
    Cancer Lett; 2023 Jan; 553():215996. PubMed ID: 36343787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of immune dysfunction in sepsis: inducible nitric oxide-meditated alterations in p38 MAPK activation.
    Song GY; Chung CS; Jarrar D; Cioffi WG; Ayala A
    J Trauma; 2002 Aug; 53(2):276-82; discussion 282-3. PubMed ID: 12169934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymicrobial sepsis enhances clearance of apoptotic immune cells by splenic macrophages.
    Swan R; Chung CS; Albina J; Cioffi W; Perl M; Ayala A
    Surgery; 2007 Aug; 142(2):253-61. PubMed ID: 17689693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of T cells suppression by dendritic cells transfected with VSIG4 recombinant adenovirus.
    Xu S; Sun Z; Li L; Liu J; He J; Song D; Shan G; Liu H; Wu X
    Immunol Lett; 2010 Jan; 128(1):46-50. PubMed ID: 19914289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myelin-phagocytosing macrophages modulate autoreactive T cell proliferation.
    Bogie JF; Stinissen P; Hellings N; Hendriks JJ
    J Neuroinflammation; 2011 Jul; 8():85. PubMed ID: 21781347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. VSIG4-expressing tumor-associated macrophages impair anti-tumor immunity.
    Jung K; Jeon YK; Jeong DH; Byun JM; Bogen B; Choi I
    Biochem Biophys Res Commun; 2022 Nov; 628():18-24. PubMed ID: 36063598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular Histone H3 Induces Pyroptosis During Sepsis and May Act Through NOD2 and VSIG4/NLRP3 Pathways.
    Shi CX; Wang Y; Chen Q; Jiao FZ; Pei MH; Gong ZJ
    Front Cell Infect Microbiol; 2020; 10():196. PubMed ID: 32432055
    [No Abstract]   [Full Text] [Related]  

  • 20. Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production.
    Yamazaki T; Akiba H; Koyanagi A; Azuma M; Yagita H; Okumura K
    J Immunol; 2005 Aug; 175(3):1586-92. PubMed ID: 16034097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.